Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Metabolism of Eicar (5-Ethynyl-1-β-D- Ribofuranosylimidazole-4-Carboxamide),A Potent Inhibitor of Inosinate Dehydrogenase — Jan Balzarini (1998) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Metabolism of Eicar (5-Ethynyl-1-β-D- Ribofuranosylimidazole-4-Carboxamide),A Potent Inhibitor of Inosinate Dehydrogenase
Shared by
De Clercq Erik
KU Leuven
Metabolism of Eicar (5-Ethynyl-1-β-D- Ribofuranosylimidazole-4-Carboxamide),A Potent Inhibitor of Inosinate Dehydrogenase
Article
1998
en
Authors
+3 more
JB
Jan Balzarini
LS
L. Stet
AM
Akira Matsuda
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1993
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Jan Balzarini
,
Anna Karlsson
,
L Wang
,
Christina Bohman
,
K. Horská
,
Ivan Votruba
,
Arnold Fridland
,
Arthur Van Aerschot
,
Piet Herdewijn
,
De Clercq Erik
Article
1997
Metabolism of eicar (5-ethynyl-1-B-dribofurano-sylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase
Jan Balzarini
,
L. Stet
,
Akihiko Matsuda
,
Leonard I. Wiebe
,
E. Knauss
,
De Clercq Erik
Article
1991
Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds
De Clercq Erik
,
Marina Cools
,
Jan Balzarini
,
Robert Snoeck
,
Graciela Andreï
,
Mitsuaki Hosoya
,
Shirô Shigeta
,
Takuya Ueda
,
Noriaki Minakawa
,
Akira Matsuda
Article
1993
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2′,5′-Bis-O-(tert-butyldimethylsilyl)-β-d-ribofuranosyl]-3-N-methyl-thymine]-3′-spiro-5″-(4″-amino-1″,2″-oxathiole-
Jan Balzarini
,
Lieve Naesens
,
Christina Bohman
,
María‐Jesús Pérez‐Pérez
,
Ana San‐Félix
,
Marı́a-José Camarasa
,
De Clercq Erik
Article
1996
ChemInform Abstract: Synthesis, Conformational Analysis and Biological Evaluation of 2‐(5‐ Deoxy‐β‐D‐ribofuranosyl)pyridine‐4‐carboxamide.
Pieter Joos
,
Alex De Groot
,
E. L. Esmans
,
F. C. Alderweireldt
,
A. DE BRUYN
,
Jan Balzarini
,
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.